临床合理用药杂志
臨床閤理用藥雜誌
림상합리용약잡지
CHINESE JOURNAL OF CLINICAL RATIONAL DRUG USE
2014年
32期
11-12
,共2页
苟晓琴%李世云%李勤%甘莉%饶进%熊萍%李强%李龙英%廖琬
茍曉琴%李世雲%李勤%甘莉%饒進%熊萍%李彊%李龍英%廖琬
구효금%리세운%리근%감리%요진%웅평%리강%리룡영%료완
血 25 羟维生素 D%健康成年女性%维生素 D2 针剂%维生素 D3 注射液%维生素 D 缺乏
血 25 羥維生素 D%健康成年女性%維生素 D2 針劑%維生素 D3 註射液%維生素 D 缺乏
혈 25 간유생소 D%건강성년녀성%유생소 D2 침제%유생소 D3 주사액%유생소 D 결핍
25-hydroxy vitamin D%Female healthy adult%Vitamin D2 injection%Vitamin D3 injection%Vitamin D defi-ciency
目的:比较维生素 D2注射液与维生素 D3注射液在治疗健康女性维生素 D 缺乏或不足时对血25羟维生素 D 水平的影响。方法选择常住成都市且年龄在40~55岁的健康女性94名,随机将其分为 D2组和 D3组各47例。D2组给予维生素 D2注射液,每次7.5mg(30万 U),每2周注射1次,共注射4次;D3组给予维生素 D3注射液,每次7.5mg(30万 U),每2周注射1次,共注射4次。分别于治疗前、最后1次注射后2周采静脉血测定血清25羟维生素 D,血清钙、磷、镁,血清甲状旁腺素(PTH)及血清骨源性碱性磷酸酶(BAP)。结果治疗后,D2组和 D3组血清25羟 D 水平明显升高,差异有统计学意义(P <0.01);且治疗后 D3组25羟 D 水平高于 D2组,差异有统计学意义(P <0.01)。治疗前后,2组血清磷、血清 PTH 均降低,差异有统计学意义(P <0.01),血清钙、血清镁、血清 BAP 无明显变化,差异无统计学意义(P >0.05)。未出现维生素 D 中毒或药物相关不良反应表现。结论维生素 D 针剂无论是 D2还是 D3治疗维生素 D 缺乏或不足都是有效的,但在相同用法条件下 D3比 D2升高血清25羟 D 水平的幅度更大。维生素 D 注射剂30万 U 每2周1次共4次治疗维生素 D 不足或缺乏是安全的。
目的:比較維生素 D2註射液與維生素 D3註射液在治療健康女性維生素 D 缺乏或不足時對血25羥維生素 D 水平的影響。方法選擇常住成都市且年齡在40~55歲的健康女性94名,隨機將其分為 D2組和 D3組各47例。D2組給予維生素 D2註射液,每次7.5mg(30萬 U),每2週註射1次,共註射4次;D3組給予維生素 D3註射液,每次7.5mg(30萬 U),每2週註射1次,共註射4次。分彆于治療前、最後1次註射後2週採靜脈血測定血清25羥維生素 D,血清鈣、燐、鎂,血清甲狀徬腺素(PTH)及血清骨源性堿性燐痠酶(BAP)。結果治療後,D2組和 D3組血清25羥 D 水平明顯升高,差異有統計學意義(P <0.01);且治療後 D3組25羥 D 水平高于 D2組,差異有統計學意義(P <0.01)。治療前後,2組血清燐、血清 PTH 均降低,差異有統計學意義(P <0.01),血清鈣、血清鎂、血清 BAP 無明顯變化,差異無統計學意義(P >0.05)。未齣現維生素 D 中毒或藥物相關不良反應錶現。結論維生素 D 針劑無論是 D2還是 D3治療維生素 D 缺乏或不足都是有效的,但在相同用法條件下 D3比 D2升高血清25羥 D 水平的幅度更大。維生素 D 註射劑30萬 U 每2週1次共4次治療維生素 D 不足或缺乏是安全的。
목적:비교유생소 D2주사액여유생소 D3주사액재치료건강녀성유생소 D 결핍혹불족시대혈25간유생소 D 수평적영향。방법선택상주성도시차년령재40~55세적건강녀성94명,수궤장기분위 D2조화 D3조각47례。D2조급여유생소 D2주사액,매차7.5mg(30만 U),매2주주사1차,공주사4차;D3조급여유생소 D3주사액,매차7.5mg(30만 U),매2주주사1차,공주사4차。분별우치료전、최후1차주사후2주채정맥혈측정혈청25간유생소 D,혈청개、린、미,혈청갑상방선소(PTH)급혈청골원성감성린산매(BAP)。결과치료후,D2조화 D3조혈청25간 D 수평명현승고,차이유통계학의의(P <0.01);차치료후 D3조25간 D 수평고우 D2조,차이유통계학의의(P <0.01)。치료전후,2조혈청린、혈청 PTH 균강저,차이유통계학의의(P <0.01),혈청개、혈청미、혈청 BAP 무명현변화,차이무통계학의의(P >0.05)。미출현유생소 D 중독혹약물상관불량반응표현。결론유생소 D 침제무론시 D2환시 D3치료유생소 D 결핍혹불족도시유효적,단재상동용법조건하 D3비 D2승고혈청25간 D 수평적폭도경대。유생소 D 주사제30만 U 매2주1차공4차치료유생소 D 불족혹결핍시안전적。
Objective To compare the efficiency of vitamin D2 and vitamin D3 in raising the 25-hydroxyvitamin D (25(OH)D)status of female healthy adults working indoor. Methods 94 healthy women coming from Chengdu City and who were in 40 ~ 55 years old were randomly divided into Group D2(n = 47,treated with vitamin D2 injection 7. 5mg every two weeks for four times)and Group D3(n = 47,treated with D3 injection as the same way). The serum 25(OH)D,parathyroid hormone(PTH),bone alkaline phosphatase(BAP),serum calcium and phosphorus were measured before and after the inter-vention. Results After treatment,the average 25(OH)D level of Group D2、D3 increased significantly,the difference was sta-tistically significant(P < 0. 01). The 25(OH)D level of Group D3 was higher than Group D2 ,the difference was statistically significant(P < 0. 01). The PTH and serum phosphorus of both groups decreased,the difference was statistically significant (P < 0. 01). There were no significant change of serum calcium,BAP and serum magnesium(P > 0. 05). There was no vitamin D intoxication or related adverse reactions after intervention. Conclusion vitamin D2 and vitamin D3 are both effect,but Vita-min D3 injection is more efficient than Vitamin D2 injection in raising the 25-hydroxyvitamin D status of female healthy adults with vitamin D deficiency. The method that vitamin D 3 injection 300000 U every two weeks for four times is safe.